Prediction of Neutropenic Events in Chemotherapy Patients: A Machine Learning Approach
- 1 December 2021
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 5 (5) , 904-911
Abstract
PURPOSE: Severe and febrile neutropenia present serious hazards to patients with cancer undergoing chemotherapy. We seek to develop a machine learning–based neutropenia prediction model that can be used to assess risk at the initiation of a chemotherapy cycle. MATERIALS AND METHODS: We leverage rich electronic medical records (EMRs) data from a large health care system and apply machine learning methods to predict severe and febrile neutropenic events. We outline the data curation process and challenges posed by EMRs data. We explore a range of algorithms with an emphasis on model interpretability and ease of use in a clinical setting. RESULTS: Our final proposed model demonstrates an out-of-sample area under the receiver operating characteristic curve of 0.865 (95% CI, 0.830 to 0.891) in the prediction of neutropenic events on the basis of only 20 clinical features. The model validates known risk factors and offers insight into potential novel clinical indicators and treatment characteristics that elevate risk. It relies on factors that are directly extractable from EMRs, provided a tool can be easily integrated into existing workflows. A cost-based analysis provides insight into optimal risk thresholds and offers a framework for tailoring algorithms to individual hospital needs. CONCLUSION: A better understanding of neutropenic risk on an individual level enables a more informed approach to patient monitoring and treatment decisions.Keywords
This publication has 16 references indexed in Scilit:
- Towards trustable machine learningNature Biomedical Engineering, 2018
- Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2018
- Optimal classification treesMachine Learning, 2017
- Predicting neutropenia risk in patients with cancer using electronic dataJournal of the American Medical Informatics Association, 2016
- Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in KoreaOncology, 2016
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2015
- Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation StudyPLOS ONE, 2014
- Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapyCancer, 2010
- Development and validation of a prediction model for the risk of developing febrile neutropenia in the first cycle of chemotherapy among elderly patients with breast, lung, colorectal, and prostate cancerSupportive Care in Cancer, 2010
- Random ForestsMachine Learning, 2001